OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective
Nicoletta Cordani, Tommaso Bianchi, Luca Carlofrancesco Ammoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11890-11890
Open Access | Times Cited: 15
Nicoletta Cordani, Tommaso Bianchi, Luca Carlofrancesco Ammoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11890-11890
Open Access | Times Cited: 15
Showing 15 citing articles:
Edaravone: A Novel Possible Drug for Cancer Treatment?
Elisa Duranti, Nicoletta Cordani, Chiara Villa
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1633-1633
Open Access | Times Cited: 10
Elisa Duranti, Nicoletta Cordani, Chiara Villa
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1633-1633
Open Access | Times Cited: 10
Current HRD assays in ovarian cancer: differences, pitfalls, limitations, and novel approaches
Federica Guffanti, Ilaria Mengoli, Giovanna Damia
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Federica Guffanti, Ilaria Mengoli, Giovanna Damia
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Extracellular Vesicles in Ovarian Cancer: From Chemoresistance Mediators to Therapeutic Vectors
Muttiah Barathan, Nur Dina Muhammad Fuad, Faizul Jaafar, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1806-1806
Open Access | Times Cited: 4
Muttiah Barathan, Nur Dina Muhammad Fuad, Faizul Jaafar, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1806-1806
Open Access | Times Cited: 4
Opportunities for predictive proteogenomic biomarkers of drug treatment sensitivity in epithelial ovarian cancer
Trudy Janice Philips, Britt Erickson, Stefani N. Thomas
Frontiers in Oncology (2025) Vol. 14
Open Access
Trudy Janice Philips, Britt Erickson, Stefani N. Thomas
Frontiers in Oncology (2025) Vol. 14
Open Access
Beyond the BRCA1/2 genes in ovarian cancer: the role of germline pathogenic variants in the ATM gene
Daniele Guadagnolo, Angelo Minucci, Antonella Chiavassa, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Open Access
Daniele Guadagnolo, Angelo Minucci, Antonella Chiavassa, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Open Access
Unveiling the Role of JAK2/STAT3 Signaling in Chemoresistance of Gynecological Cancers: From Mechanisms to Therapeutic Implications
Tianxiao Zhang, Chang Xiaohan
Critical Reviews in Oncology/Hematology (2025), pp. 104712-104712
Closed Access
Tianxiao Zhang, Chang Xiaohan
Critical Reviews in Oncology/Hematology (2025), pp. 104712-104712
Closed Access
Comparative effectiveness and safety of treatment regimens for recurrent advanced ovarian cancer: a systematic review and network meta-analysis
Xingfa Huo, Tian Tian, Xiaochun Zhang, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Xingfa Huo, Tian Tian, Xiaochun Zhang, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Precision Medicine in High-Grade Serous Ovarian Cancer: Targeted Therapies and the Challenge of Chemoresistance
Sara Polajžer, Katarina Černe
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2545-2545
Open Access
Sara Polajžer, Katarina Černe
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2545-2545
Open Access
Spotlight on New Hallmarks of Drug-Resistance towards Personalized Care for Epithelial Ovarian Cancer
Simona Frezzini, Sara Lonardi
Cells (2024) Vol. 13, Iss. 7, pp. 611-611
Open Access | Times Cited: 2
Simona Frezzini, Sara Lonardi
Cells (2024) Vol. 13, Iss. 7, pp. 611-611
Open Access | Times Cited: 2
Effects of PARP Inhibitors on Subsequent Platinum-Based Chemotherapy in Patients with Recurrent Ovarian Cancer
Tetsuya Kokabu, Yosuke Tarumi, K. Aoki, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2651-2651
Open Access | Times Cited: 2
Tetsuya Kokabu, Yosuke Tarumi, K. Aoki, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2651-2651
Open Access | Times Cited: 2
Molecular mechanisms restoring olaparib efficacy through ATR/CHK1 pathway inhibition in olaparib-resistant BRCA1/2MUT ovarian Cancer models
Łukasz Biegała, Małgorzata Statkiewicz, Arkadiusz Gajek, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024), pp. 167574-167574
Open Access | Times Cited: 2
Łukasz Biegała, Małgorzata Statkiewicz, Arkadiusz Gajek, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024), pp. 167574-167574
Open Access | Times Cited: 2
Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial–Mesenchymal Transition in an Ovarian Tumor
Xi Chen, Yuanliang Yan, Yuanhong Liu, et al.
Journal of Natural Products (2024) Vol. 87, Iss. 4, pp. 837-848
Closed Access | Times Cited: 1
Xi Chen, Yuanliang Yan, Yuanhong Liu, et al.
Journal of Natural Products (2024) Vol. 87, Iss. 4, pp. 837-848
Closed Access | Times Cited: 1
Spotlight on New Hallmarks of Drug-Resistance towards Personalized Care for Epithelial Ovarian Cancer
Simona Frezzini, Sara Lonardi
(2024)
Open Access
Simona Frezzini, Sara Lonardi
(2024)
Open Access
Poly(Adenosine Diphosphate Ribose) Polymerase (PARP) Inhibitors in the Treatment of Advanced Ovarian Cancer: A Narrative Review
Deepika Dewani, Arpita Jaiswal, Pravin Karwade
Cureus (2024)
Open Access
Deepika Dewani, Arpita Jaiswal, Pravin Karwade
Cureus (2024)
Open Access
The new prospectives of statins in combination therapies for ovarian cancer based on connections of mechanisms
Xinya Zhang, Yuliang Zou
Authorea (Authorea) (2023)
Open Access
Xinya Zhang, Yuliang Zou
Authorea (Authorea) (2023)
Open Access
